Predictive factors of chemotherapy‑induced nausea and vomiting in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy: A retrospective study

Yao,Fei; He,Lijuan; Sun,Xingyu

doi:10.3892/ol.2025.14913

Predictive factors of chemotherapy‑induced nausea and vomiting in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy: A retrospective study

Authors:
- Fei Yao
- Lijuan He
- Xingyu Sun
View Affiliations

Affiliations: Department of Gynecology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Health Management Center, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Gynecology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China
Published online on: February 4, 2025 https://doi.org/10.3892/ol.2025.14913
Article Number: 167

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chemotherapy‑induced nausea and vomiting (CINV) is a common and distressing adverse effect in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy. The present study aimed to identify predictors of CINV in this population. A retrospective analysis was conducted of 209 elderly patients with gynecological cancer treated with paclitaxel and carboplatin chemotherapy at The Affiliated Hospital, Southwest Medical University (Luzhou, China) between May 2019 and July 2023. The Multinational Association of Supportive Care in Cancer Antiemesis Tool (MAT) was used to assess the presence, frequency, and severity of CINV. Patients were categorized into the CINV group (n=76) and non‑CINV group (n=133) based on the MAT results. Age, hypertension, pre‑chemotherapy sleep duration and pre‑chemotherapy anxiety level were identified as significant predictors of CINV in the univariate analysis. In the multivariate analysis, age, pre‑chemotherapy sleep duration and pre‑chemotherapy anxiety level remained significant predictors. In conclusion, age, pre‑chemotherapy sleep duration and pre‑chemotherapy anxiety level are significant predictors of CINV in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy. These findings could help in tailoring preventative strategies for CINV in this population.

View Figures

View References

1	Escobar Y, Cajaraville G, Virizuela JA, Álvarez R, Muñoz A, Olariaga O, Tamés MJ, Muros B, Lecumberri MJ, Feliu J, et al: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual data of vomiting incidence by chemotherapy evaluation) study. Support Care Cancer. 23:2833–2840. 2015. View Article : Google Scholar : PubMed/NCBI
2	Hayashi T, Shimokawa M, Matsuo K, Iihara H, Kawada K, Nakano T and Egawa T: Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: A propensity score-matched analysis. BMC Cancer. 21:742021. View Article : Google Scholar : PubMed/NCBI
3	Gupta K, Walton R and Kataria SP: Chemotherapy-induced nausea and vomiting: Pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 26:1002782021. View Article : Google Scholar : PubMed/NCBI
4	Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, et al: Randomized, double-blind, phase III study of fosnetupitant versus fosaprepitant for prevention of highly emetogenic chemotherapy-induced nausea and vomiting: CONSOLE. J Clin Oncol. 40:180–188. 2022. View Article : Google Scholar : PubMed/NCBI
5	Herrstedt J, Lindberg S and Petersen PC: Prevention of chemotherapy-induced nausea and vomiting in the older patient: Optimizing outcomes. Drugs Aging. 39:1–21. 2022. View Article : Google Scholar : PubMed/NCBI
6	Samami E, Shahhosseini Z, Hamzehgardeshi Z and Elyasi F: Psychological interventions in chemotherapy-induced nausea and vomiting in women with breast cancer: A systematic review. Iran J Med Sci. 47:95–106. 2022.PubMed/NCBI
7	Yoshikawa K, Higashijima J, Okitsu H, Miyake H, Yagi T, Miura M, Bando Y, Ando T, Hotchi M, Ishikawa M, et al: Effects of chemotherapy on quality of life and night-time sleep of colon cancer patients. J Med Invest. 67:338–342. 2020. View Article : Google Scholar : PubMed/NCBI
8	Li W, Zhou Q, Liu W, Xu C, Tang ZR, Dong S, Wang H, Li W, Zhang K, Li R, et al: A machine learning-based predictive model for predicting lymph node metastasis in patients with Ewing's sarcoma. Front Med (Lausanne). 9:8321082022. View Article : Google Scholar : PubMed/NCBI
9	Dong S, Yang H, Tang ZR, Ke Y, Wang H, Li W and Tian K: Development and validation of a predictive model to evaluate the risk of bone metastasis in kidney cancer. Front Oncol. 11:7319052021. View Article : Google Scholar : PubMed/NCBI
10	Rizzo A, Mollica V, Tateo V, Tassinari E, Marchetti A, Rosellini M, De Luca R, Santoni M and Massari F: Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study. Cancer Immunol Immunother. 72:1381–1394. 2023. View Article : Google Scholar : PubMed/NCBI
11	Rizzo A, Santoni M, Mollica V, Logullo F, Rosellini M, Marchetti A, Faloppi L, Battelli N and Massari F: Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: The MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 17:1455–1466. 2021. View Article : Google Scholar : PubMed/NCBI
12	Rizzo A: Immune checkpoint inhibitors and mismatch repair status in advanced endometrial cancer: Elective affinities. J Clin Med. 11:39122022. View Article : Google Scholar : PubMed/NCBI
13	Guven DC, Erul E, Kaygusuz Y, Akagunduz B, Kilickap S, De Luca R and Rizzo A: Immune checkpoint inhibitor-related hearing loss: A systematic review and analysis of individual patient data. Support Care Cancer. 31:6242023. View Article : Google Scholar : PubMed/NCBI
14	Sahin TK, Rizzo A, Aksoy S and Guven DC: Prognostic significance of the Royal Marsden Hospital (RMH) score in patients with cancer: A systematic review and meta-analysis. Cancers (Basel). 16:18352024. View Article : Google Scholar : PubMed/NCBI
15	Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
16	Zung WW: A rating instrument for anxiety disorders. Psychosomatics. 12:371–379. 1971. View Article : Google Scholar : PubMed/NCBI
17	Buysse DJ, Reynolds CF III, Monk TH, Berman SR and Kupfer DJ: The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213. 1989. View Article : Google Scholar : PubMed/NCBI
18	Zung WW: A self-rating depression scale. Arch Gen Psychiatry. 12:63–70. 1965. View Article : Google Scholar : PubMed/NCBI
19	Tan JY, Suen LK and Molassiotis A: Psychometric assessment of the Chinese version of the MASCC antiemesis tool (MAT) for measuring chemotherapy-induced nausea and vomiting. Support Care Cancer. 24:3729–3737. 2016. View Article : Google Scholar : PubMed/NCBI
20	Huang SH and O'Sullivan B: Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 18:402017. View Article : Google Scholar : PubMed/NCBI
21	Hohenegger M: Pharmacokinetic considerations in geriatric cancer patients. Memo. 14:11–14. 2021. View Article : Google Scholar
22	Williams GR, Outlaw D, Harvey RD, Lichtman SM, Zamboni WC and Giri S: Chemotherapy dosing in older adults with cancer: One size does NOT fit all. J Geriatr Oncol. 14:1013632023. View Article : Google Scholar : PubMed/NCBI
23	Mosa ASM, Hossain AM, Lavoie BJ and Yoo I: Patient-related risk factors for chemotherapy-induced nausea and vomiting: A systematic review. Front Pharmacol. 11:3292020. View Article : Google Scholar : PubMed/NCBI
24	Schmitz NCM, van der Werf YD and Lammers-van der Holst HM: The importance of sleep and circadian rhythms for vaccination success and susceptibility to viral infections. Clocks Sleep. 4:66–79. 2022. View Article : Google Scholar : PubMed/NCBI
25	Quesnel C, Savard J, Simard S, Ivers H and Morin CM: Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol. 71:189–200. 2003. View Article : Google Scholar : PubMed/NCBI
26	Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC and Agrawal S: One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol. 27:6033–6040. 2009. View Article : Google Scholar : PubMed/NCBI
27	Bai L, Ni L, Lu J, Zhang YY, Yin Y, Zhang W and Duan X: Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy. Front Oncol. 14:13966372024. View Article : Google Scholar : PubMed/NCBI
28	Gonzalez-Ling A, Galindo Vázquez O, Espinoza Bello M, Robles R, Rascón-Gasca ML, Lara-Mejía L, Heredia D and Arrieta O: Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer. Palliat Support Care. 21:608–615. 2023. View Article : Google Scholar : PubMed/NCBI
29	Lin LY, Lin LH, Tzeng GL, Huang YH, Tai JF, Chen YL, Wu CJ, Chen PH, Lin PC and Hung PL: Effects of mindfulness-based therapy for cancer patients: A systematic review and meta-analysis. J Clin Psychol Med Settings. 29:432–445. 2022. View Article : Google Scholar : PubMed/NCBI
30	Kang C: Approach the prevention of chemotherapy-induced nausea and vomiting in older patients with care. Drugs & Therapy Perspectives. 38:483–488. 2022. View Article : Google Scholar
31	Affronti ML, Lee J, Molassiotis A, Johnson L, Tinianov S, Clark-Snow R and Scotte F: MASCC 2023 patient-centered antiemetic guidelines and education statements: An evidence-based and consensus resource for patients. Support Care Cancer. 32:3352024. View Article : Google Scholar : PubMed/NCBI